CN109091590A - A kind of ginseng and astragalus hepar kang tablet and preparation method thereof - Google Patents
A kind of ginseng and astragalus hepar kang tablet and preparation method thereof Download PDFInfo
- Publication number
- CN109091590A CN109091590A CN201811181235.XA CN201811181235A CN109091590A CN 109091590 A CN109091590 A CN 109091590A CN 201811181235 A CN201811181235 A CN 201811181235A CN 109091590 A CN109091590 A CN 109091590A
- Authority
- CN
- China
- Prior art keywords
- parts
- astragalus
- ginseng
- tablet
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of ginseng and astragalus hepar kang tablets and preparation method thereof, it is made of multiple raw materials, the material component comprising following parts by weight: 3-6 parts of rhizoma cyperi, 4-9 parts of Radix Codonopsis, 4-6 parts of cortex moutan, 4-9 parts of Schisandra chinensis, 6-12 parts of Radix Angelicae Sinensis, 9-16 parts of Radix Astragali, 1-2 parts of wilsonii, 2-4 parts of Rhizoma Chuanxiong, 1-2 parts of cape jasmine.Using a kind of new formula, the effect of the hepatopathys such as treatment chronic hepatitis is preferable, and dosage form is tablet, it for mostly a kind of selection of sufferer, can solve in previous such Chinese medicine treatment that effect is not obvious enough, take effect slower problem, there is significant effect, the advantages of drug effect is definite, quick result.
Description
Technical field
The invention belongs to the field of Chinese medicines more particularly to a kind of ginseng and astragalus hepar kang tablet and preparation method thereof.
Background technique
Chronic hepatitis is mainly to develop from oxyhepatitis, the one kind of chronic hepatitis as hepatitis.Suffer from Chronic Liver
Scorching Symptoms mainly include the following types:
1, symptom of digestive tract: since liver is the digestive organs of human body, the bile of hepatic secretion is necessary to food digestion.Liver
When scorching, dysfunction of liver, bile secretion is reduced, and influences the digestion and absorption of food.Therefore, often there is appetite not in chronic hepatitis
The symptom of the discomfort such as oil, abdominal distension is detested in vibration, nausea.
Symptom out of strength: due to liver inflammation, consumption increases, and has taken the photograph the substance of people because of liver function damage, cannot abundant generation
It thanks, meets the needs of body, therefore symptom out of strength occur.
2, the symptom of hepatalgia: lack pain nerve, the typically no violent pain of chronic hepatitis inside liver.But liver
Surface have one layer of very thin film, claim Glisson's capsule, have pain nerve distribution on Glisson's capsule, when liver inflammation enlargement, Glisson's capsule
Anxiety, pain nerve is stimulated, thus some patientss can have upper right abdomen, secret anguish, tenderness or percussion pain.
3, the symptom of liver fibrosis: if chronic hepatitis inflammation is not cured for a long time, fibrous connective tissue increases in recurrent exerbation liver
It is raw, and its degrading activity relative deficiency, therefore a large amount of extrtacellular matrix depositions get off to form liver fibrosis.If liver fibrosis is same
When with lobuli hepatis structure destruction, then referred to as cirrhosis.
4: due to liver damage, there is endocrine disorder in the outer symptom of liver, and cutaneous pigmentation leads to hepatic face occur,
It is also possible to will appear the clinical symptoms such as liver palms, spider angioma.
Ginseng and astragalus hepar kang capsule, is mainly used for clearing damp heat-clearing, regulating the function of the liver and spleen, for urgency caused by retention of damp-heat in the interior, incoordination between the liver and the spleen,
Chronic hepatitis.The formula generally used is Radix Angelicae Sinensis, Radix Codonopsis, milk thistle, Schisandra chinensis, oriental wormwood, Radix Astragali, Extractum Acanthopanacis Senticosi, formula compared with
For fixation, curative effect is single, currently used for treat chronic hepatitis Chinese patent drug in addition to there are also hepatosis treating ginseng-astragalus bolus for ginseng and astragalus hepar kang capsule, but
It is in alternative dosage form still without tablet.
Summary of the invention
In order to overcome the above problems of the prior art, a kind of ginseng and astragalus hepar kang tablet is provided, is made of multiple raw materials, is wrapped
Material component containing following parts by weight: 3-6 parts of rhizoma cyperi, 4-9 parts of Radix Codonopsis, 4-6 parts of cortex moutan, 4-9 parts of Schisandra chinensis, Radix Angelicae Sinensis 6-12
Part, 9-16 parts of Radix Astragali, 1-2 parts of wilsonii, 2-4 parts of Rhizoma Chuanxiong, 1-2 parts of cape jasmine.
Preferably: the material component comprising following parts by weight: 3 parts of rhizoma cyperi, 4 parts of Radix Codonopsis, 4 parts of cortex moutan, Schisandra chinensis 4
Part, 6 parts of Radix Angelicae Sinensis, 9 parts of Radix Astragali, 1 part of wilsonii, 2 parts of Rhizoma Chuanxiong, 1 part of cape jasmine.
Any of the above-described scheme is preferably: the material component comprising following parts by weight: 5 parts of rhizoma cyperi, 6 parts of Radix Codonopsis, cortex moutan 5
Part, 7 parts of Schisandra chinensis, 9 parts of Radix Angelicae Sinensis, 13 parts of Radix Astragali, 1.5 parts of wilsonii, 3 parts of Rhizoma Chuanxiong, 1.5 parts of cape jasmine.
Any of the above-described scheme is preferably: the material component comprising following parts by weight: 6 parts of rhizoma cyperi, 9 parts of Radix Codonopsis, cortex moutan 6
Part, 9 parts of Schisandra chinensis, 12 parts of Radix Angelicae Sinensis, 16 parts of Radix Astragali, 2 parts of wilsonii, 4 parts of Rhizoma Chuanxiong, 2 parts of cape jasmine.
Invention additionally discloses a kind of preparation methods of ginseng and astragalus hepar kang tablet, comprising the following steps:
(1) rhizoma cyperi, Radix Codonopsis, cortex moutan, Schisandra chinensis, Radix Angelicae Sinensis, Radix Astragali, wilsonii, Rhizoma Chuanxiong, cape jasmine are milled to powder by, according to the ratio
It is sieved in batch plant, is weighed after sieving；
(2) mixes load weighted raw material, sets incorporation time, revolving speed, releases raw material after mixing；
(3) the raw material tabletting that will be mixed, is dispensed after tabletting, sets bag chartered plane horizontal sealing temperature and longitudinal sealing temperature is divided
Dress；
(4) after the completion of packaging, the qualified storage of product laboratory detection.
Any of the above-described scheme is preferably: being needed before step (1) sieving to rhizoma cyperi powder, codonopsis pilosula powder, cortex moutan powder, five
Taste powder, angelica powder, astragalus membranaceus powder, wilsonii powder, Rhizoma Chuanxiong power, gardenia powder are tested, after the assay was approved according to the ratio in burden charging carriage
Between be sieved.
Any of the above-described scheme is preferably: the incorporation time in step (2) is 20-40 minutes, 30-50 revs/min.
Any of the above-described scheme is preferably: the incorporation time in step (2) is 30 minutes, 40 revs/min.
Any of the above-described scheme is preferably: the mixing machine in step (2) is -600 mixing machine of V-type.
Any of the above-described scheme is preferably: bag chartered plane model DXD-400B in step (3), bag chartered plane horizontal sealing temperature 150-
170 degree, longitudinal sealing temperature 130-140 degree.
Any of the above-described scheme is preferably: 160 degree of temperature of bag chartered plane horizontal sealing in step (3), and 135 degree of longitudinal sealing temperature.
Any of the above-described scheme is preferably: after step (3) further include: packaged pouch is carried out outer packing, paper
Box coding date of manufacture, every box fill 30 bags, and box outer patch sealing label, the box installed is packed into big case, and every case fills 60 boxes.
Rhizoma cyperi in the application formula, pungent, slight bitter, are put down at micro-sweet, and liver and spleen tri-jiao channel, function soothing liver-qi stagnation, qi-regulating tune are entered
In, regulating the flow of vital energy and dispeling melancholy is used for stagnation of QI due to depression of the liver, chest, the side of body, abdominal distention.
Radix Codonopsis also known as Shangdang ginseng, windproof Radix Codonopsis, kurarinone, are the dryings of Campanulaceae Radix Codonopsis, codonopsis pilosula var. modesta, radix codonpsis tangshen
Root, Radix Codonopsis is sweet natured, return lung, the spleen channel, for obtaining indigestion, physically weak, burnout, anorexia and loose stool caused by treatment deficiency of spleen-QI
And the symptoms such as chronic cough caused by lung qi lung qi virtual loss is more than, shortness of breath and palpitation, the low lazy speech of sound, spontaneous sweating have preferable treatment
Effect.The root bark of tree peony also known as cortex moutan, moutan root bark, red root, are ranunculaceae peony dry root skin, and property is bitter, pungent, slightly cold, are had
Clearing heat and cooling blood activates blood circulation and disperses blood clots and other effects, and the root bark of tree peony enters after body the toughness that can reduce capillary well, and help inhibits body
The siltation of interior blood platelet has the function of thinking activating microcirculation and removing stasis medicinal.The primary efficacy of Schisandra chinensis, which has, to astringe the lung to stop cough, it can treat lung
The empty and cough drawn, can treat night sweat due to yin deficiency either spontaneous perspiration due to deficiency of vital energy.Radix Angelicae Sinensis, sweet Wen Zhirun is the key medicine that enriches blood for conscience
The deficiency of blood, sallow complexion, dizziness palpitaition etc., replenishing and activating blood, and and can eliminating cold to stop pain, activating microcirculation and removing stasis medicinal, be used for the deficiency of blood, stasis and have concurrently
Cold solidifying and traumatic injury, the pain card of wind-damp numbness.Radix Astragali, slightly warm in nature sweet in flavor.Return lung, spleen, liver and kidney channel.Polishing consolidates table,
Torr sore myogenic.Cure mainly physically weak spontaneous perspiration, chronic diarrhea, rectal prolapse, uterine prolapse, chronic nephritis, physically weak edema, chronic ulcer, the open sore part is long not
Healing.
Wilsonii, activate blood circulation and disperse blood clots effect, promotes blood circulation.
Rhizoma Chuanxiong, blood-activating and qi-promoting, wind-expelling pain-stopping.
Cape jasmine, bitter cold drop clearly, can rush down the fire-evil of Whole Body up and down clearly, thus can purge the sthenic heart-fire and relieving restlessness and restlessness, can be with
It treats and vexed, dry disturbs the discomforts such as not peaceful.Can also be used to treat pyreticosis fire toxin is flourishing and the high fever that shows is irritated, coma and delirium
Etc. illnesss.Cape jasmine bitter cold energy eliminating dampness, energy heat-clearing of trembling with fear, and it is good at the lower burnt liver and gallbladder damp-heat of clear benefit, it can treat caused by liver and gallbladder damp-heat
Jaundice with damp-heat pathogen symptom；In addition, cape jasmine can clearing away the damp-heat from the lower-jiao, clearing heat and cooling blood, inducing diuresis for treating strangurtia can be used to treat blood strangury, heat
Drench the urine malaise symptoms such as puckery pain.Cape jasmine can purging fire for removing toxin, clearing away the liver-fire with improving eyesight, can treat liver and gallbladder it is burning hot on attack caused by
The ophthalmic uncomfortables illness such as red eye, swell pain.
Beneficial effect
The present invention provides a kind of ginseng and astragalus hepar kang tablet and preparation method thereof, provides a kind of ginseng and astragalus hepar kang tablet, is made of multiple raw materials, wraps
Material component containing following parts by weight: 3-6 parts of rhizoma cyperi, 4-9 parts of Radix Codonopsis, 4-6 parts of cortex moutan, 4-9 parts of Schisandra chinensis, Radix Angelicae Sinensis 6-12
Part, 9-16 parts of Radix Astragali, 1-2 parts of wilsonii, 2-4 parts of Rhizoma Chuanxiong, 1-2 parts of cape jasmine.Using a kind of new formula, treatment chronic hepatitis etc.
The effect of hepatopathy is preferable, and dosage form is tablet, and for mostly a kind of selection of sufferer, it is not bright enough to can solve effect in previous such Chinese medicine treatment
Show, take effect slower problem, there is significant effect, the advantages of drug effect is definite, quick result.
Specific embodiment
In order to be best understood from technical solution of the present invention and advantage, below by way of specific embodiment, to the present invention do into
One step explanation.
Embodiment 1
A kind of ginseng and astragalus hepar kang tablet is made of multiple raw materials, the material component comprising following parts by weight: 3 parts of rhizoma cyperi, 4 parts of Radix Codonopsis, male
4 parts of the root bark of tree peony, 4 parts of Schisandra chinensis, 6 parts of Radix Angelicae Sinensis, 9 parts of Radix Astragali, 1 part of wilsonii, 2 parts of Rhizoma Chuanxiong, 1 part of cape jasmine.
Preparation method: the said goods are examined 3 parts qualified of raw material rhizoma cyperi, 4 parts of Radix Codonopsis, cortex moutan 4 by ginseng and astragalus hepar kang tablet
Part, 4 parts of Schisandra chinensis, 6 parts of Radix Angelicae Sinensis, 9 parts of Radix Astragali, 1 part of wilsonii, 2 parts of Rhizoma Chuanxiong, 1 part of cape jasmine be milled to powder, by technology preparation match
In batch plant 80 mesh of sieving, all materials electronic scale between weighing is weighed after sieving；
V-type compound department is transmitted to by sterile transferring window the load weighted material in workshop is weighed, material is launched to V-type -600
In mixing machine, set incorporation time 30 minutes by technique requirement, 40 revs/min, when mixing pours nitrogen.With stainless after mixing
Steel drum releases material；
The material mixed is transmitted between bag hired car by sterile transferring window and is dispensed, bag chartered plane model DXD-400B, if
Determine 160 degree of temperature of bag chartered plane horizontal sealing, 145 degree of longitudinal sealing temperature, every bag of 6 grams of packing net content, the net content of inspection in every 10 minutes,
It is required that net content reaches 0.5 gram；
By packaged pouch by sterile transferring window be transmitted to outsourcing workshop carry out outer packing, the carton coding date of manufacture,
Every box fills 10 bags, and box outer patch sealing label, the box installed is packed into big case, and every case fills 60 boxes；
The qualified storage of product laboratory detection.
Embodiment 2
A kind of ginseng and astragalus hepar kang tablet is made of multiple raw materials, the material component comprising following parts by weight: 5 parts of rhizoma cyperi, 6 parts of Radix Codonopsis, male
5 parts of the root bark of tree peony, 7 parts of Schisandra chinensis, 9 parts of Radix Angelicae Sinensis, 13 parts of Radix Astragali, 1.5 parts of wilsonii, 3 parts of Rhizoma Chuanxiong, 1.5 parts of cape jasmine.
Ginseng and astragalus hepar kang tablet, preparation method: by the said goods examine qualified raw material rhizoma cyperi, Radix Codonopsis, cortex moutan, Schisandra chinensis,
Radix Angelicae Sinensis, Radix Astragali, wilsonii, Rhizoma Chuanxiong, cape jasmine are milled to powder, by technology preparation proportion in batch plant 80 mesh of sieving, institute after sieving
There is material electronic scale between weighing to be weighed；
V-type compound department is transmitted to by sterile transferring window the load weighted material in workshop is weighed, material is launched to V-type -600
In mixing machine, set incorporation time 30 minutes by technique requirement, 40 revs/min, when mixing pours nitrogen.With stainless after mixing
Steel drum releases material；
The material mixed is transmitted between bag hired car by sterile transferring window and is dispensed, bag chartered plane model DXD-400B, if
Determine 160 degree of temperature of bag chartered plane horizontal sealing, 145 degree of longitudinal sealing temperature, every bag of 6 grams of packing net content, the net content of inspection in every 10 minutes,
It is required that net content reaches 0.5 gram；
By packaged pouch by sterile transferring window be transmitted to outsourcing workshop carry out outer packing, the carton coding date of manufacture,
Every box fills 10 bags, and box outer patch sealing label, the box installed is packed into big case, and every case fills 60 boxes；
The qualified storage of product laboratory detection.
Embodiment 3
A kind of ginseng and astragalus hepar kang tablet is made of multiple raw materials, the material component comprising following parts by weight: 6 parts of rhizoma cyperi, 9 parts of Radix Codonopsis, male
6 parts of the root bark of tree peony, 9 parts of Schisandra chinensis, 12 parts of Radix Angelicae Sinensis, 16 parts of Radix Astragali, 2 parts of wilsonii, 4 parts of Rhizoma Chuanxiong, 2 parts of cape jasmine.
Ginseng and astragalus hepar kang tablet, preparation method: by the said goods examine qualified raw material rhizoma cyperi, Radix Codonopsis, cortex moutan, Schisandra chinensis,
Radix Angelicae Sinensis, Radix Astragali, wilsonii, Rhizoma Chuanxiong, cape jasmine are milled to powder, by technology preparation proportion in batch plant 80 mesh of sieving, institute after sieving
There is material electronic scale between weighing to be weighed；
V-type compound department is transmitted to by sterile transferring window the load weighted material in workshop is weighed, material is launched to V-type -600
In mixing machine, set incorporation time 30 minutes by technique requirement, 40 revs/min, when mixing pours nitrogen.With stainless after mixing
Steel drum releases material；
The material mixed is transmitted between bag hired car by sterile transferring window and is dispensed, bag chartered plane model DXD-400B, if
Determine 160 degree of temperature of bag chartered plane horizontal sealing, 145 degree of longitudinal sealing temperature, every bag of 6 grams of packing net content, the net content of inspection in every 10 minutes,
It is required that net content reaches 0.5 gram；
By packaged pouch by sterile transferring window be transmitted to outsourcing workshop carry out outer packing, the carton coding date of manufacture,
Every box fills 10 bags, and box outer patch sealing label, the box installed is packed into big case, and every case fills 60 boxes；
The qualified storage of product laboratory detection.
Embodiment 4
Unlike a kind of ginseng and astragalus hepar kang tablet and embodiment 1, it is made of multiple raw materials, 5 parts of rhizoma cyperi, 6 parts of Radix Codonopsis, cortex moutan 3
Part, 7 parts of Schisandra chinensis, 9 parts of Radix Angelicae Sinensis, 13 parts of Radix Astragali, 1.5 parts of wilsonii, 3 parts of Rhizoma Chuanxiong, 1.5 parts of cape jasmine.
Embodiment 5
A kind of ginseng and astragalus hepar kang tablet is made of multiple raw materials, the material component comprising following parts by weight: 7 parts of rhizoma cyperi, 6 parts of Radix Codonopsis, male
5 parts of the root bark of tree peony, 7 parts of Schisandra chinensis, 9 parts of Radix Angelicae Sinensis, 13 parts of Radix Astragali, 1.5 parts of wilsonii, 3 parts of Rhizoma Chuanxiong, 1.5 parts of cape jasmine.
To examine therapeutic effect of the invention, 60 tcm diagnosis chronic hepatitis patients are chosen, wherein male 28, female
Property 22, the age 26-69 years old, selection criteria: limb was soft out of strength, weak from head to foot；Face is pitch-dark, has hepatic face；Hepatic region is hidden
Bitterly；Liver fibrosis is serious；Liver function transaminase is lasting abnormal, and other indexs such as plasma albumin, blood total bilirubin etc. are no
It is qualified.Symptom as above can be made a definite diagnosis.60 patients are randomly divided into six groups, and it is to control that 1- of embodiment of the present invention embodiment 3, which is respectively adopted,
Treatment group, embodiment 4 and embodiment 5 and common Western medicine method are treated as a control group, wherein treatment group 1- treatment group 3
The ginseng and astragalus hepar kang tablet of embodiment 1- embodiment 3 is taken, control group 1, control group 2 take the ginseng and astragalus hepar kang of embodiment 4 and embodiment 5
Piece, control group 3 are treated using common Western medicine method.
Efficacy determination:
It is effective: alleviation out of strength, with it energetically；Receiving poor, abdominal distension, dull pain in liver alleviates, and hepatic region is comfortable；Hepatic face is taken on a new look,
Face becomes pale；Liver fibrosis inspection is alleviated obvious；The indexs such as liver function test transaminase, plasma albumin are obviously improved.
Effective: solution out of strength, with it energetically, abdominal distension, poor, hepatic face of receiving are alleviated.
Invalid: illness is unchanged.
(2) efficacy analysis
One time four, three times per day, 60 sufferers complete trimestral treatment.It personal patient information and takes rear situation and sees below
Shown in table 1
1 personal patient information of table and curative effect situation
Show that there is apparent therapeutic effect after taking ginseng and astragalus hepar kang tablet of the invention by the data in table 1.Treatment group
In 30 patients, 21 significant in efficacy, effective 25 are treated, effective percentage is accounts for 83.33%, wherein in treatment group 2, effectively
Rate is up to 90%.It is shown by above-mentioned data, ginseng and astragalus hepar kang tablet of the invention has the function of significantly treating chronic hepatitis, controls
Therapeutic effect is preferable.
It should be noted that the above embodiments are only used to illustrate the technical solution of the present invention., rather than its limitations；Although
Present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that: it is still
It is possible to modify the technical solutions described in the foregoing embodiments, or some or all of the technical features is carried out
Equivalent replacement；And these are modified or replaceed, it does not separate the essence of the corresponding technical solution various embodiments of the present invention technical side
The range of case.
Claims (10)
1. a kind of ginseng and astragalus hepar kang tablet is made of multiple raw materials, it is characterised in that: the material component comprising following parts by weight: rhizoma cyperi
3-6 parts, 4-9 parts of Radix Codonopsis, 4-6 parts of cortex moutan, 4-9 parts of Schisandra chinensis, 6-12 parts of Radix Angelicae Sinensis, 9-16 parts of Radix Astragali, 1-2 parts of wilsonii, river
2-4 parts of rhizome of chuanxiong, 1-2 parts of cape jasmine.
2. a kind of ginseng and astragalus hepar kang tablet as described in claim 1, it is characterised in that: the material component comprising following parts by weight: fragrant
Attached 3 parts, 4 parts of Radix Codonopsis, 4 parts of cortex moutan, 4 parts of Schisandra chinensis, 6 parts of Radix Angelicae Sinensis, 9 parts of Radix Astragali, 1 part of wilsonii, 2 parts of Rhizoma Chuanxiong, 1 part of cape jasmine.
3. a kind of ginseng and astragalus hepar kang tablet as described in claim 1, it is characterised in that: the material component comprising following parts by weight: fragrant
Attached 5 parts, 6 parts of Radix Codonopsis, 5 parts of cortex moutan, 7 parts of Schisandra chinensis, 9 parts of Radix Angelicae Sinensis, 13 parts of Radix Astragali, 1.5 parts of wilsonii, 3 parts of Rhizoma Chuanxiong, cape jasmine
1.5 part.
4. a kind of ginseng and astragalus hepar kang tablet as described in claim 1, it is characterised in that: the material component comprising following parts by weight: fragrant
Attached 6 parts, 9 parts of Radix Codonopsis, 6 parts of cortex moutan, 9 parts of Schisandra chinensis, 12 parts of Radix Angelicae Sinensis, 16 parts of Radix Astragali, 2 parts of wilsonii, 4 parts of Rhizoma Chuanxiong, cape jasmine 2
Part.
5. such as the preparation method of ginseng and astragalus hepar kang tablet of any of claims 1-4, it is characterised in that: including following step
It is rapid:
Rhizoma cyperi, Radix Codonopsis, cortex moutan, Schisandra chinensis, Radix Angelicae Sinensis, Radix Astragali, wilsonii, Rhizoma Chuanxiong, cape jasmine are milled to powder, according to the ratio in ingredient
Workshop sieving, weighs after sieving；
Load weighted raw material is mixed, incorporation time, revolving speed is set, releases raw material after mixing；
The raw material tabletting that will be mixed, is dispensed after tabletting, sets bag chartered plane horizontal sealing temperature and longitudinal sealing temperature is dispensed；
After the completion of packaging, the qualified storage of product laboratory detection.
6. a kind of preparation method of ginseng and astragalus hepar kang tablet as claimed in claim 5, it is characterised in that: before step (1) sieving
Need to rhizoma cyperi powder, codonopsis pilosula powder, cortex moutan powder, Fructus Schisandrae Chinensis powder, angelica powder, astragalus membranaceus powder, wilsonii powder, Rhizoma Chuanxiong power, gardenia powder into
Performing check is sieved in batch plant according to the ratio after the assay was approved.
7. a kind of preparation method of ginseng and astragalus hepar kang tablet as claimed in claim 5, it is characterised in that: when mixing in step (2)
Between be 20-40 minutes, 30-50 revs/min.
8. a kind of preparation method of ginseng and astragalus hepar kang tablet as claimed in claim 5, it is characterised in that: when mixing in step (2)
Between be 30 minutes, 40 revs/min.
9. a kind of preparation method of ginseng and astragalus hepar kang tablet as claimed in claim 5, it is characterised in that: the mixing machine in step (2)
For -600 mixing machine of V-type.
10. a kind of preparation method of ginseng and astragalus hepar kang tablet as claimed in claim 5, it is characterised in that: also wrapped after step (3)
It includes: packaged pouch being subjected to outer packing, carton coding date of manufacture, every box fills 30 bags, and box outer patch sealing label install
Box is packed into big case, and every case fills 60 boxes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811181235.XA CN109091590A (en) | 2018-10-11 | 2018-10-11 | A kind of ginseng and astragalus hepar kang tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811181235.XA CN109091590A (en) | 2018-10-11 | 2018-10-11 | A kind of ginseng and astragalus hepar kang tablet and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109091590A true CN109091590A (en) | 2018-12-28 |
Family
ID=64868477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811181235.XA Withdrawn CN109091590A (en) | 2018-10-11 | 2018-10-11 | A kind of ginseng and astragalus hepar kang tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109091590A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181341A (en) * | 2007-11-23 | 2008-05-21 | 包头中药有限责任公司 | Mass control method of ginseng and astragalus hepar kang tablet |
| CN101843694A (en) * | 2009-09-25 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating chronic hepatitis |
| CN106942727A (en) * | 2017-04-20 | 2017-07-14 | 北京市永康年健康科技有限责任公司 | It is a kind of to be used to reduce DHA algal oil product of blood fat and its preparation method and application |
-
2018
- 2018-10-11 CN CN201811181235.XA patent/CN109091590A/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101181341A (en) * | 2007-11-23 | 2008-05-21 | 包头中药有限责任公司 | Mass control method of ginseng and astragalus hepar kang tablet |
| CN101843694A (en) * | 2009-09-25 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating chronic hepatitis |
| CN106942727A (en) * | 2017-04-20 | 2017-07-14 | 北京市永康年健康科技有限责任公司 | It is a kind of to be used to reduce DHA algal oil product of blood fat and its preparation method and application |
Non-Patent Citations (2)
| Title |
|---|
| 彭铭泉等: "《肝脏病药膳》", 31 May 2004, 青海人民出版社 * |
| 黄方正等: "自拟加味越鞠丸治疗脂肪肝90例疗效观察", 《甘肃中医》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103041282B (en) | Traditional Chinese medicine for treating deficiency of spleen and kidney and preparation method of medicine | |
| CN101502634B (en) | Chinese medicinal composition for treating uterine blood flow and preparation method thereof | |
| CN102166317B (en) | Traditional Chinese medicine combination for curing metrorrhagia and metrostaxis | |
| CN109966462A (en) | A kind of herbal paste and preparation method thereof improving constitution | |
| CN102526498B (en) | Chinese medicine for eliminating toxic and side effects after nasopharyngeal carcinoma radiotherapy and preparation method and administration way thereof | |
| CN102580000B (en) | Medicament for curing cancer pain and preparation method thereof | |
| CN101579471B (en) | Medicine for curing diabetes | |
| CN102716361A (en) | Blood-glucose-lowering and pancreatic-islet-recovering plaster | |
| CN102362934A (en) | Chinese patent medicine for treating erythema nodosum | |
| CN101797342A (en) | Traditional Chinese medicine for treating rheumatoid and chronic infectious arthritis | |
| CN102335249B (en) | Oral capsule for treating II-type diabetes | |
| CN103285343A (en) | Medicine for treating liver cancer and preparation method thereof | |
| CN109091590A (en) | A kind of ginseng and astragalus hepar kang tablet and preparation method thereof | |
| CN106389950A (en) | Traditional Chinese medicine preparation for treating proteinuria of chronic nephritic syndrome | |
| CN102228576B (en) | Chinese patent medicine for treating discoid lupus erythematosus | |
| CN101632831B (en) | Traditional Chinese medicine medicated wine for treating waist and leg pains | |
| CN104547553A (en) | Traditional Chinese medicine for treating nervous endocrine disorder | |
| CN104398789A (en) | Traditional Chinese medicine decoction for treating iron-deficiency anemia | |
| CN100411681C (en) | Medicine for shortening lying-in time and treating artificial abortion sequela | |
| CN102362957B (en) | Chinese prepared medicine for treating deep lupus erythematosus | |
| CN102743682B (en) | Chinese medicinal pill for preventing miscarriage of pregnant woman | |
| CN101647965A (en) | Internal medicine for treating chronic nephritis | |
| CN106266838A (en) | A kind of for Chinese medicine composition treating stranguria and preparation method thereof | |
| CN104435900A (en) | Medicine for treating rheumatic arthritis and preparation method | |
| CN104825909A (en) | TCM (traditional Chinese medicine) preparation for renal cancer and preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20181228 |